Patient Access to Rencell in China Harvard Case Solution & Analysis

Patient Access to Rencell in China Case Solution

Abstract:
Rencell is a targeted treatment versus metastatic kidney cell cancer, which considerably extends disease-free survival. Rencell's worldwide wholesale cost of $1,000 for one month of treatment makes the drug unaffordable for lots of clients in China. What prices method should Axios International, a health care consultancy, advise to Paracelsus, the big biopharmaceutical business which markets Rencell?

Pedagogical Goals:
Rates technique for a life-prolonging medication in a nation where couple of clients can manage to pay the global cost. Secret principles: - capability to pay, price - market access - rate discrimination, separated rates - business social duty

This is just an excerpt. This case is about Marketing

published: 24 Jun 2013

Patient Access to Rencell in China Case Solution Other Similar Case Solutions like

Patient Access to Rencell in China

Share This